Canada markets close in 4 hours 14 minutes
  • S&P/TSX

    20,010.19
    -611.20 (-2.96%)
     
  • S&P 500

    4,261.31
    -136.63 (-3.11%)
     
  • DOW

    33,419.09
    -846.28 (-2.47%)
     
  • CAD/USD

    0.7877
    -0.0071 (-0.89%)
     
  • CRUDE OIL

    82.89
    -2.25 (-2.64%)
     
  • BTC-CAD

    43,400.18
    -1,593.48 (-3.54%)
     
  • CMC Crypto 200

    778.83
    -31.77 (-3.92%)
     
  • GOLD FUTURES

    1,833.40
    +1.60 (+0.09%)
     
  • RUSSELL 2000

    1,947.88
    -40.04 (-2.01%)
     
  • 10-Yr Bond

    1.7250
    -0.0220 (-1.26%)
     
  • NASDAQ

    13,252.60
    -516.33 (-3.75%)
     
  • VOLATILITY

    35.04
    +6.19 (+21.46%)
     
  • FTSE

    7,307.71
    -186.42 (-2.49%)
     
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     
  • CAD/EUR

    0.6963
    -0.0041 (-0.59%)
     

Is Exelixis, Inc.'s (NASDAQ:EXEL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • EXEL

Most readers would already be aware that Exelixis' (NASDAQ:EXEL) stock increased significantly by 13% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually dictate market outcomes. Particularly, we will be paying attention to Exelixis' ROE today.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Put another way, it reveals the company's success at turning shareholder investments into profits.

View our latest analysis for Exelixis

How Is ROE Calculated?

ROE can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Exelixis is:

4.6% = US$94m ÷ US$2.0b (Based on the trailing twelve months to June 2021).

The 'return' is the amount earned after tax over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.05.

What Is The Relationship Between ROE And Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company’s earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.

A Side By Side comparison of Exelixis' Earnings Growth And 4.6% ROE

When you first look at it, Exelixis' ROE doesn't look that attractive. Next, when compared to the average industry ROE of 19%, the company's ROE leaves us feeling even less enthusiastic. In spite of this, Exelixis was able to grow its net income considerably, at a rate of 23% in the last five years. Therefore, there could be other reasons behind this growth. For instance, the company has a low payout ratio or is being managed efficiently.

As a next step, we compared Exelixis' net income growth with the industry and found that the company has a similar growth figure when compared with the industry average growth rate of 24% in the same period.

past-earnings-growth
past-earnings-growth

Earnings growth is a huge factor in stock valuation. It’s important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is Exelixis fairly valued compared to other companies? These 3 valuation measures might help you decide.

Is Exelixis Efficiently Re-investing Its Profits?

Exelixis doesn't pay any dividend to its shareholders, meaning that the company has been reinvesting all of its profits into the business. This is likely what's driving the high earnings growth number discussed above.

Summary

In total, it does look like Exelixis has some positive aspects to its business. Even in spite of the low rate of return, the company has posted impressive earnings growth as a result of reinvesting heavily into its business. With that said, the latest industry analyst forecasts reveal that the company's earnings are expected to accelerate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting